Bronstein Ben - Insider Non-Derivative Transactions at Aldeyra Therapeutics, Inc. (ALDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 27, 2023, Bronstein Ben's relationship to Aldeyra Therapeutics, Inc. (ALDX) is Director, and currently has 28,248 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALDX insiders.
Data Source: SEC.
Bronstein Ben - Insider Non-Derivative Transactions at ALDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 28, 2023 | M -- (Common Stock) | 9604 | 0.55 | 28248 |